Filing Flows › Elevance Health (ELV) › Capital expenditures
Elevance Health (ELV) capital expenditures by quarter
Elevance Health's capital expenditures were $267M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 7 quarters it ranged from $196M (Q1 2025) to $360M (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $267M | -7% | -26% |
| Q2 2026 | $287M | +22% | +7% |
| Q1 2026 | $235M | -20% | +20% |
| Q4 2025 | $293M | -19% | — |
| Q3 2025 | $360M | +35% | — |
| Q2 2025 | $267M | +36% | — |
| Q1 2025 | $196M | — | — |
Q3 2026 at a glance
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
Questions
What is Elevance Health's capital expenditures?
Elevance Health's capital expenditures were $267M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has Elevance Health's capital expenditures changed?
Over the last 7 quarters it ranged from $196M (Q1 2025) to $360M (Q3 2025).